Navigation Links
Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
Date:2/5/2008

, single-administration, placebo-controlled study in

approximately 160 migraine patients with or without aura. Three doses

of AZ-104 (1.25, 2.5 and 5 mg) were evaluated against placebo in the

clinical trial. Using the IHS (International Headache Society) 4-point

rating scale, the primary efficacy endpoint is pain-relief response at

2 hours post-administration. Alexza expects preliminary findings to be

released by the end of Q1 2008. AZ-104 is being developed through

Symphony Allegro.

-- AZ-002 (Staccato alprazolam) is being developed for the acute treatment

of panic attacks associated with panic disorder. Alexza is conducting

a Phase 2a proof-of-concept clinical trial in panic disorder patients.

The primary aim of the in-clinic clinical trial is to assess the safety

and efficacy of a single dose of AZ-002 in treating a

pharmacologically-induced panic attack. Alexza has completed the

open-label, lead-in segment of the clinical trial, identifying the 1 mg

AZ-002 dose as an acceptable dose in terms of its safety and efficacy

profile, and has initiated the randomized, double blind,

placebo-controlled segment of the clinical trial. Alexza expects the

enrollment of this clinical trial to be completed by the end of Q2

2008. AZ-002 is being developed through Symphony Allegro.

-- AZ-003 (Staccato fentanyl) is being developed for the treatment of

breakthrough pain in cancer and non-cancer patients. In December 2007,

Alexza entered into a license and development agreement with Endo

Pharmaceuticals Holdings Inc. for development of AZ-003 and the

fentanyl class of molecules in North America. In the partnership,

Alexza has primary responsibility for the development of the Staccato

Electric Multiple Dose device and the exclusive right to manufactu
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 Unchained Labs, a refreshingly ... this year,s PEGS conference and launches the UNit — ... biologics. PEGS: The Essential Protein Engineering Summit takes place ... The UNit lets drug discovery researchers look ... out there. Its 7 applications, 144 sample a day ...
(Date:5/4/2015)...  Geneia, a company of experienced healthcare change ... healthcare efficiencies, today announced a first-of-its-kind partnership with ... use Geneia,s advanced analytics solution coupled with its ... lower the cost of patient care. ... utilization data from multiple sources to create a ...
(Date:5/4/2015)... Ohio , May 4, 2015 The ... Workforce Survey, which confirmed that pharmacy has shifted toward ... as active pharmacists and managers, there is an incredible ... pharmacists in the next decade. In ... leadership site, Essential Insights , Eden Sulzer, ...
Breaking Medicine Technology:Unchained Labs Lets the UNit Loose 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 3Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 2Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 3
... Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company ... financial results for the three months ended September 30, ... 2009 , As of September 30, 2009, Orexigen ... an additional $50.9 million in investment securities, available-for-sale. ...
... , FRANKLIN, Mass., Nov. 4 Echo Therapeutics, Inc. ... the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, ... SkinPrep System for transdermal drug delivery announced today that ... Transdermal Continuous Glucose Monitoring System (tCGM System) in patients ...
Cached Medicine Technology:Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 2Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 3Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 4Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 5Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 6Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 7Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 8Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 9Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 10Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 2Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 3
(Date:5/4/2015)... 04, 2015 World T.E.A.M. Sports’ best-attended ... ride in the last decade arrived in this historic ... in two days from the Pentagon in Arlington, Virginia. ... registered disabled and able-bodied participants work together to successfully ... and honors the commitment and sacrifices by military veterans ...
(Date:5/4/2015)... May 04, 2015 Scanmarket, a leading ... has been included in the just-released Spend Matters “50 ... the Spend Matters " 50 To Know " listing ... of Scanmarket’s commitment to providing comprehensive, easy-to-use strategic sourcing ... Nielsen, “There are many well-established and respected companies on ...
(Date:5/4/2015)... Fast on the heels of Autism Awareness ... Allison Folmar, JD, join over 150 speakers in the ... Sunday, May 24, the conference presents "I Know You're ... interested in Ryan Hinds' recovery story? The book ... autism was written by Marcia Hinds, Ryan’s mom. ...
(Date:5/4/2015)... Texas (PRWEB) May 04, 2015 Peacock ... about our mothers. He said, “My mother was the most ... Day, wrap her in lovely, feminine prints and textures ... , Look no further than the Eloise Robe to get ... feel with its cap sleeve and tapered waist. It is ...
(Date:5/4/2015)... Diego, CA (PRWEB) May 04, 2015 ... New Cireson Platform to strengthen ... Cireson offers customers a choice to consume Microsoft System ... or Hyper-V on premise , Company transitioning ... model , Continuous innovation with expanding new ...
Breaking Medicine News(10 mins):Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 3Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 4Health News:Scanmarket Selected to Spend Matters "50 To Know" List of Companies in Procurement Sector. 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 2Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 3Health News:Cireson Unveils New Microsoft Cloud & System Center Strategy 4
... aware of the prevalence of mental health issues and ... we to help the many people who contend with ... of the Canadian Journal of Psychiatry have ... and substance use services to adequately address the needs ...
... donated eggs to fertility clinics reported satisfaction with the ... and 20 percent reported lasting psychological effects, according to ... donation. , The research by scientists at the University ... in 20 states and is the largest study to ...
... LifeBanc, the nonprofit,organ and tissue recovery organization for Northeast ... conference announcing the first,near total face transplant in the ... The following statement is from LifeBanc Chief Executive Officer ... keeping with LifeBanc,s mission of helping to improve and ...
... Filled More Than 1 Million Prescriptions , ... Services, Inc., a wholly owned subsidiary of the Cystic Fibrosis ... services to the cystic fibrosis (CF) community nationwide. , ... 1988 with one patient, one prescription and a mission to ...
... Dynatronics Corporation (Nasdaq: DYNT ) today ... execution of an agreement with a former director for ... improved corporate profitability. On December 15, 2008, the company ... consulting services through its principal, Mark Crockett. As a ...
... Compliance through Patient Engagement , , ... to improve patient safety and standards compliance, GetWellNetwork, Inc. ... is enabling King,s Daughters Medical Center (KDMC) to meet the ... 16 through GetWellNetwork,s interactive PatientLife System(R) . , ...
Cached Medicine News:Health News:National rates of co-occurring substance use and mental disorders call for better service integration 2Health News:National rates of co-occurring substance use and mental disorders call for better service integration 3Health News:Most women report satisfaction with egg donation; some claim problems 2Health News:Most women report satisfaction with egg donation; some claim problems 3Health News:LifeBanc Assists Cleveland Clinic in First Near Total Face Transplant in the United States 2Health News:Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary 2Health News:Dynatronics Announces Changes to Board and Launches Operational Improvement Process 2Health News:King's Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16 2Health News:King's Daughters Medical Center Leverages Unique Bedside Interactive Technology to Meet Requirements of Patient Safety Goal 16 3
... to three conventional measurement modes (Phakic, Aphakic, ... a new axial length measuring mode. Normal ... sonic velocity for conversion at 1550m/s. The ... calculating each tissues sonic velocity for conversion: ...
... A-Scan/Pachymeter with graphic display and IOL ... A-Scan/Pachymeter combination units include firmware module ... Binkhorst II formulas. Audible tones increase ... to visual axis. Constant tone when ...
... the world's first very high frequency digital ... technology, Artemis provides microscopic resolution images and ... anterior segments of the human eye. Artemis ... eye scanner. In use, the patient leans ...
... The ISYSTEM-ABD ("I-cubed") is an ... featuring an analog oscilloscope (static deflection) ... and resolution than low cost video ... hyaloid, syneresis, inflammatory cells, as well ...
Medicine Products: